重新思考“抗肥胖药物”这一标签。 - Suppr

Suppr

超能文献

Rethinking the label anti-obesity medication.

作者信息

Flint Stuart W

机构信息

School of Psychology, University of Leeds, Leeds LS29JU, UK; Scaled Insights, Nexus, University of Leeds, Leeds, UK.

出版信息

Lancet Diabetes Endocrinol. 2024 May;12(5):301-302. doi: 10.1016/S2213-8587(24)00071-8.

DOI:10.1016/S2213-8587(24)00071-8

PMID:38663947

Abstract

摘要

相似文献

Rethinking the label anti-obesity medication.

Lancet Diabetes Endocrinol. 2024 May;12(5):301-302. doi: 10.1016/S2213-8587(24)00071-8.

Reasons to not rethink the label anti-obesity medication.

Lancet Diabetes Endocrinol. 2024 Sep;12(9):613-614. doi: 10.1016/S2213-8587(24)00216-X.

Nonincretin drugs in later-stage development.

Am J Manag Care. 2014 Jan;20(1 Spec No.):E2.

Another type of intervention: treating obesity with medication.

J Am Diet Assoc. 2005 Jun;105(6):895-8. doi: 10.1016/j.jada.2005.03.004.

Should family physicians prescribe medication for obesity? YES.

Can Fam Physician. 2017 Feb;63(2):102-103.

Should family physicians prescribe medication for obesity? NO.

Can Fam Physician. 2017 Feb;63(2):103-105.

Anti-Obesity Pharmacotherapy: The Intercontinental Regulatory Divide.

Drugs. 2015 Jun;75(9):931-3. doi: 10.1007/s40265-015-0404-z.

New medications and new ways to use them.

Obesity (Silver Spring). 2015 Apr;23 Suppl 1:S1-4. doi: 10.1002/oby.21091.

Drug treatment of obesity.

Psychiatr Clin North Am. 2005 Mar;28(1):193-217, ix-x. doi: 10.1016/j.psc.2004.09.009.

[Drug treatment of obesity: present and future].

An Med Interna. 1997 Jun;14(6):271-4.

引用本文的文献

The Weight of Cardiovascular Diseases: Addressing the Global Cardiovascular Crisis Associated with Obesity.

Glob Heart. 2025 Aug 21;20(1):68. doi: 10.5334/gh.1451. eCollection 2025.

The Impact of Novel Medications for Obesity on Weight Stigma and Societal Attitudes: A Narrative Review.

Curr Obes Rep. 2025 Feb 5;14(1):18. doi: 10.1007/s13679-025-00611-5.

Balancing the Scale: Weighing In on Communicating About Diabetes and Weight.

Am J Lifestyle Med. 2024 Dec 4:15598276241304622. doi: 10.1177/15598276241304622.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Rethinking the label anti-obesity medication.

Lancet Diabetes Endocrinol. 2024 May;12(5):301-302. doi: 10.1016/S2213-8587(24)00071-8.

Reasons to not rethink the label anti-obesity medication.

Lancet Diabetes Endocrinol. 2024 Sep;12(9):613-614. doi: 10.1016/S2213-8587(24)00216-X.

Nonincretin drugs in later-stage development.

Am J Manag Care. 2014 Jan;20(1 Spec No.):E2.

Another type of intervention: treating obesity with medication.

J Am Diet Assoc. 2005 Jun;105(6):895-8. doi: 10.1016/j.jada.2005.03.004.

Should family physicians prescribe medication for obesity? YES.

Can Fam Physician. 2017 Feb;63(2):102-103.

Should family physicians prescribe medication for obesity? NO.

Can Fam Physician. 2017 Feb;63(2):103-105.

Anti-Obesity Pharmacotherapy: The Intercontinental Regulatory Divide.

Drugs. 2015 Jun;75(9):931-3. doi: 10.1007/s40265-015-0404-z.

New medications and new ways to use them.

Obesity (Silver Spring). 2015 Apr;23 Suppl 1:S1-4. doi: 10.1002/oby.21091.

Drug treatment of obesity.

Psychiatr Clin North Am. 2005 Mar;28(1):193-217, ix-x. doi: 10.1016/j.psc.2004.09.009.

[Drug treatment of obesity: present and future].

An Med Interna. 1997 Jun;14(6):271-4.

引用本文的文献

The Weight of Cardiovascular Diseases: Addressing the Global Cardiovascular Crisis Associated with Obesity.

Glob Heart. 2025 Aug 21;20(1):68. doi: 10.5334/gh.1451. eCollection 2025.

The Impact of Novel Medications for Obesity on Weight Stigma and Societal Attitudes: A Narrative Review.

Curr Obes Rep. 2025 Feb 5;14(1):18. doi: 10.1007/s13679-025-00611-5.

Balancing the Scale: Weighing In on Communicating About Diabetes and Weight.

Am J Lifestyle Med. 2024 Dec 4:15598276241304622. doi: 10.1177/15598276241304622.